GS-5734

GS-5734

GS-5734

Min.Order / FOB Price:Get Latest Price

1 Gram

Negotiable

  • Min.Order :1 Gram
  • Purity: 97%(HPLC)
  • Payment Terms : T/T,,MoneyGram,Other

Keywords

Remdesivir GS 5734 GS5734

Quick Details

  • Appearance:Solid powder
  • Application:For research only.
  • PackAge:
  • ProductionCapacity:10|Gram|Month
  • Storage:Dry, dark and at 0 - 4 C for short term (days to weeks) or -20 C for long term (months to years).
  • Transportation:Shipped under ambient temperature as non-hazardous chemical. This product is stable enough for a few weeks during ordinary shipping and time spent in Customs.

Superiority:

This is our mature product with high quality and competitive price. It is not in stock and may be available through custom synthesis. The estimated lead time is 2 months. Please send email to lalpharmsales@gmail.com to inquire quote. Welcome to order it as well as customized it. Also, we would like to develop strategic partnership with our clients.

 


 

Details:

LAL ID:xqy-1701001

Name: Remdesivir

IUPAC/Chemical Name: 2-ethylbutyl ((S)-(((2R,3S,4R,5R)-5-(4-aminopyrrolo[1,2-b]pyridazin-7-yl)-5-cyano-3,4-dihydroxytetrahydrofuran-2-yl)methoxy)(phenoxy)phosphoryl)-L-alaninate

Synonym: Remdesivir; GS-5734; GS 5734; GS5734.

CAS#: 1809249-37-3

Chemical Formula: C28H36N5O8P

Exact Mass: 601.2301

Molecular Weight: 601.5968

Description: Remdesivir, also known as GS-5734, is an antiviral drug, a novel nucleotide analog prodrug. It was developed by Gilead Sciences as a treatment for filovirus infections such as Ebola virus disease and Marburg virus, though it has subsequently also been found to show reasonable antiviral activity against more distantly related viruses such as respiratory syncytial virus, Junin virus, Lassa fever virus, and MERS-coronavirus. GS-5734 was rapidly pushed through clinical trials due to the 2013–2016 West African Ebola virus epidemic crisis, eventually being used in at least one human patient despite its early development stage at the time. Preliminary results have been promising, and further clinical trials are planned.

Related Searches

Confirm to collect the product to my collection?

OKCancel

About|Contact|Cas|Product Name|Molecular|Country|Encyclopedia

Message|New Cas|MSDS|Service|Advertisement|CAS DataBase|Article Data|Manufacturers | Chemical Catalog

©2008 LookChem.com,License: ICP

NO.:Zhejiang16009103

complaints:service@lookchem.com Desktop View